High-sensitivity troponin test reduces risk of future heart attack

June 4, 2018, Karolinska Institutet
Myocardial Infarction or Heart Attack. Credit: Blausen Medical Communications/Wikipedia/CC-A 3.0

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before. A new study from Karolinska Institutet in Sweden published in The Journal of the American College of Cardiology now reports that the risk of a future heart attack is lower in patients diagnosed with the new test.

A blood that measures the presence of heart-specific proteins called troponins is used by emergency clinics to diagnose myocardial infarction in patients with chest pain. For the past few years a newer laboratory method has been used at most hospitals in Sweden that is ten times more sensitive than the conventional test. The high-sensitivity troponin test can discover heart attacks earlier so that treatment can commence, which is thought to improve the patients' prognosis.

"But there is a lack of larger studies examining whether the high-sensitivity troponin test is of any significance for patients with newly diagnosed myocardial infarction in terms of survival or the risk of another heart attack," says study leader Dr. Martin Holzmann, associate professor of epidemiology at Karolinska Institutet's Department of Medicine in Solna and physician at Karolinska University Hospital.

The study included all patients in Sweden who had had their first heart attack between 2009 and 2013. This gave a study population of almost 88,000 patients, 40,000 of whom had been diagnosed using the high-sensitivity troponin test and just over 47,000 using the conventional troponin test.

The researchers found that five per cent more myocardial infarctions were being diagnosed in hospitals that used the high-sensitivity troponin test. A year after the heart attack was registered there was no difference in mortality between the two groups, although the number of new heart attacks was lower in the group that had been diagnosed using the high-sensitivity troponin test.

"This surprised us," says Dr. Holzmann. "We didn't think that the more sensitive test would affect the risk of future heart attacks."

The use of coronary angiography and balloon angioplasty was 16 and 13 per cent more common, respectively in the patients diagnosed with the high-sensitivity troponin test. In the USA, where the new test was not approved until 2017, there are fears that the more sensitive methods can entail a large increase in the number of examinations with no benefit to the patients.

"The increase we observed in our study was less than expected, which means that the high-sensitivity troponin test has enabled doctors to single out the patients who benefit from such intervention. We found no differences in medication between the two groups, so the differences in prognosis with fewer new could be attributed to the fact that more coronary angiography and balloon dilation procedures have been performed on the right ," says Dr. Holzmann, who also believes that the study supports the idea that the handful of hospitals in Sweden that still do not use the high-sensitivity troponin test should start to do so.

The study was conducted in association with the Sahlgrenska Academy and Uppsala University. Martin Holzmann receives a grant from the Swedish Heart and Lung Foundation. Per-Ola Andersson has received a lecture fee from pharmaceutical companies Roche, Gilead and Janssen and a consultancy fee from AbbVie, CTI Bipharma and Glaxo-Smith-Kline. Kai M. Eggers has received a consultancy fee from pharmaceutical company Abbott Laboratories, AstraZeneca and Fiomi Diagnostics. Martin Holzmann has received a consultancy fee from pharmaceutical companies Actelion and Pfizer. No other potential conflicts of interest have been reported.

Explore further: Troponin linked to increased risk of death

More information: "High-Sensitivity Troponins and Outcomes After Myocardial Infarction". Maria Odqvist, Per-Ola Andersson, Hans Tygesen, Kai M. Eggers, Martin J. Holzmann. Journal of the American College of Cardiology (JACC), online 4 June 2018, DOI: 10.1016/j.jacc.2018.03.515

Related Stories

Troponin linked to increased risk of death

November 3, 2017
A blood test that measures the presence of heart specific proteins called troponins is used by A&E hospitals to diagnose myocardial infarction in patients with chest pain. But even normal levels of the protein in patients ...

High-sensitivity assay gives more reassurance to chest pain patients

May 30, 2017
For some time now, patients in Sweden's emergency clinics complaining of chest pain have been evaluated using the "high-sensitivity troponin T" assay. In a large-scale registry study published in the Journal of the American ...

New heart attack test better informs of underlying condition

March 15, 2018
A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.

Heart test changes could save lives

April 25, 2017
New advice for doctors could prevent almost 3000 heart attacks being missed each year, Edinburgh researchers say. They have called for the guidelines on using blood tests to diagnose heart attacks to be urgently implemented ...

AHA: Cardiac troponin I IDs low risk of MI, cardiac death

November 13, 2017
(HealthDay)—High-sensitivity cardiac troponin I concentration can identify individuals at low risk of myocardial infarction or cardiac death within 30 days among patients with suspected acute coronary syndrome, according ...

New blood test for diagnosing heart attacks: A 'big deal,' with caveats

January 16, 2018
When diagnosing a heart attack, accuracy and timing are everything.

Recommended for you

Gout could increase heart disease risk

August 17, 2018
Having a type of inflammatory arthritis called gout may worsen heart-related outcomes for people being treated for coronary artery disease, according to new research.

Stroke patients treated at a teaching hospital are less likely to be readmitted

August 17, 2018
Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from The University of Texas Health Science ...

Cardiovascular disease related to type 2 diabetes can be reduced significantly

August 16, 2018
Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in the New England Journal of ...

Genomic autopsy can help solve unexplained cardiac death

August 15, 2018
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.

Neonatal pig hearts can heal from heart attack

August 15, 2018
While pigs still cannot fly, researchers have discovered that the hearts of newborn piglets do have one remarkable ability. They can almost completely heal themselves after experimental heart attacks.

Fifty percent of cardiovascular patients suffer from multiple diseases

August 15, 2018
New research led by The University of Western Australia has revealed that one in two patients admitted to hospital with a cardiovascular disease is suffering from multiple chronic medical conditions which required complex ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.